SOPHiA GENETICS

SOPHiA GENETICS (operating at sophiagenetics.com) is a cloud-native, AI-driven data analytics platform engineered for advancing data-driven medicine in healthcare. Founded in 2011 by biologists and headquartered in Rolle, Switzerland, with additional offices in Boston, Massachusetts, SOPHiA GENETICS addresses the critical need for real-time, actionable insights in diagnosing and treating complex diseases like cancer and rare genetic disorders. Under the hood, its SOPHiA DDM™ platform leverages artificial intelligence and multimodal data analytics—including genomics and imaging—to transform raw clinical data into precise, interpretable results. This allows clinicians and healthcare providers to deliver faster, more accurate diagnoses and personalized treatment plans. Backed by a $30 million Series D funding round led by Balderton Capital and joined by 360° Capital Partners, the company continues to scale its mission of democratizing data-driven medicine globally.